← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Clinical Trials And Surveys Co
$0
Total funding
2
Grants
Funding over time
peak $0 · FY2005–06$1$1$1$0$0
'05
'06
Funding mix
By agency
NIH$0 · 2
By mechanism
N01$0 · 2
Investigators at Clinical Trials And Surveys Co
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
ETIOLOGY OF SARCOIDOSIS A CASE CONTROL STUDY-268956075$0
N01 · FY2003 · HR
PEDIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL - MCC-268007160-268007160$0
N01 · FY2006 · HB
PEDIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL - MCC-268007160$0
N01 · FY2002 · HB
ETIOLOGY OF SARCOIDOSIS A CASE CONTROL STUDY-268956075$0
N01 · FY2002 · HR
PEDIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL - MCC-268007160$0
N01 · FY2005 · HB
PEDIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL - MCC-N01HB7160$0
N01 · FY2004 · HB
PEDIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL - MCC-268007160$0
N01 · FY2003 · HB